Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Clinical trial NCT02740777 · COMPLETED
Trial details
- NCT number
- NCT02740777
- Sponsor
- Shanghai Zerun Biotechnology Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.